Form D · Biotechnology
Thunder Biotech, Inc.
Provo, UT · CIK 0001707315
Offering snapshot reported Feb 26, 2024 · SEC filing
- Reported sold
- $100K Offering amount: $2.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 9, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 26, 2024 | Initial | $100,000 | No comparison | 2 | SEC filing |
| Oct 17, 2022 | Amendment | $1,000,000 | $0vs Oct 14, 2022 | 1 | SEC filing |
| Oct 17, 2022 | Amendment | $1,000,000 | $0vs Oct 17, 2022 | 1 | SEC filing |
| Oct 14, 2022 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Oct 11, 2022 | Initial | $4,020,000 | No comparison | 14 | SEC filing |
| Aug 22, 2022 | Initial | $9,979,274 | No comparison | 52 | SEC filing |
| Aug 22, 2022 | Initial | $8,320,515 | No comparison | 40 | SEC filing |
| Nov 6, 2017 | Initial | $325,000 | No comparison | 3 | SEC filing |
| May 23, 2017 | Initial | $770,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506016
Source: Form D, filed Feb 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Anthony Antonelli | Director |
| James Burgess | Executive |
| Jeff Hone | Director, Executive |
| D. Brent Israelsen | Director, Executive |
| Morris Linton | Executive |
| Kent Misener | Director |
| Robert P.K. Mooney | Director, Executive |
| Barry Mower | Director |
| Jeffrey Nelson | Director |
| Kim O'neill | Director, Executive |
| Scott Peterson | Director |
| D. Todd Schulthess | Director, Executive, Promoter |
| Steven Tanner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
395 Cougar Blvd. Suite 103
Provo, UT, 84604
Provo, UT, 84604